Cholinesterase Inhibitors Used for the Management of Alzheimer’s Disease: A Review
Aayushi Singh & Asha Jha · Journal of Pharmaceutical Research International · 2021
Alzheimer’s disease (AD) is defined as a progressive neurodegenerative disorder that has lately become the top reason for dementia in the elderly population (usually above 60-65 years). As mentioned before, most AD cases are sporadic and have a late onset. This disease is charact...
Open access
Research Article
10.9734/jpri/2021/v33i60A34463